Snowball logo
logo
0239_logo

Daihan Pharmaceutical Co.Ltd

023910 β€’ KQ
β‚©26,950.00-β‚©50.00Β  (0.19%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
171,462.8184,267.5195,911.5204,194.9208,614.1211,439.7
COGS
115,424124,025.7129,989.2134,406.6143,792.8147,980.6
Gross Profit
56,038.860,241.865,922.369,788.364,821.363,459.1
Operating Expenses & Income
Operating Income
28,935.232,868.135,714.338,033.631,185.729,814.6
Total Operating Expenses
142,395.1151,299.5160,116.1166,114.4177,428.4181,625.1
R&D Expenses
790.6567.91,641.21,8022,206.11,915.1
Selling General & Admin Expenses
25,471.826,22827,978.129,305.213,411.413,676
Earnings from Continuing Operations
Interest Expense
(469.3)(593.4)(52.47)(1.80534)(2.68802)(2.48644)
Interest Income
724.5418.6828.13,006.21,834.11,896.2
Income Tax Expense
------
Net Income
Net Income
22,670.424,960.528,426.333,759.127,643.826,978.4
Supplemental
EBIT
------
EBITDA
------
In millions of KRW, except % and values per 1 share